113 related articles for article (PubMed ID: 37329199)
1. Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells.
Günaydın Ş; Sulukoğlu EK; Kalın ŞN; Altay A; Budak H
J Appl Toxicol; 2023 Nov; 43(11):1676-1685. PubMed ID: 37329199
[TBL] [Abstract][Full Text] [Related]
2. Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells.
Kalın ŞN; Altay A; Budak H
Chem Biol Interact; 2022 Jul; 361():109984. PubMed ID: 35569514
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer.
Budak B; Kalın ŞN; Yapça ÖE
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1525-1535. PubMed ID: 37658214
[TBL] [Abstract][Full Text] [Related]
4. Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1.
Sulukoğlu EK; Günaydın Ş; Kalın ŞN; Altay A; Budak H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38308689
[TBL] [Abstract][Full Text] [Related]
5. Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach.
Kalın ŞN; Altay A; Budak H
J Appl Toxicol; 2023 Aug; 43(8):1148-1158. PubMed ID: 36807289
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thioredoxin reductase 1 by vulpinic acid suppresses the proliferation and migration of human breast carcinoma.
Kalın ŞN; Altay A; Budak H
Life Sci; 2022 Dec; 310():121093. PubMed ID: 36270425
[TBL] [Abstract][Full Text] [Related]
7. Lichen Acids May Be Used as A Potential Drug For Cancer Therapy; by Inhibiting Mitochondrial Thioredoxin Reductase Purified From Rat Lung.
Ozgencli I; Budak H; Ciftci M; Anar M
Anticancer Agents Med Chem; 2018; 18(11):1599-1605. PubMed ID: 29793415
[TBL] [Abstract][Full Text] [Related]
8. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
9. A thioredoxin reductase 1 inhibitor pyrano [3,2-a] phenazine inhibits A549 cells proliferation and migration through the induction of reactive oxygen species production.
Ding Q; Wang H; Wang Y; Lu Y
Mol Biol Rep; 2022 Sep; 49(9):8835-8845. PubMed ID: 35780225
[TBL] [Abstract][Full Text] [Related]
10. Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening.
Ni Y; Luo Z; Lv Y; Ma S; Luo C; Du D
Biochem Biophys Res Commun; 2023 Apr; 650():117-122. PubMed ID: 36780763
[TBL] [Abstract][Full Text] [Related]
11. Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis.
You BR; Park WH
Mol Carcinog; 2014 Nov; 53(11):847-57. PubMed ID: 23661569
[TBL] [Abstract][Full Text] [Related]
12. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
Anestål K; Arnér ES
J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
[TBL] [Abstract][Full Text] [Related]
13. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arnér ES
Free Radic Biol Med; 2009 Dec; 47(11):1661-71. PubMed ID: 19766715
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the effects of thiazole compounds on thioredoxin reductase 1 (TrxR1), glutathione S-transferase (GST), and glutathione reductase (GR) targeted human brain glioblastoma cancer (U-87 MG).
Korkmaz IN
Biotechnol Appl Biochem; 2024 Apr; ():. PubMed ID: 38682343
[TBL] [Abstract][Full Text] [Related]
15. Lichen-Derived Diffractaic Acid Inhibited Dengue Virus Replication in a Cell-Based System.
Loeanurit N; Tuong TL; Nguyen VK; Vibulakhaophan V; Hengphasatporn K; Shigeta Y; Ho SX; Chu JJH; Rungrotmongkol T; Chavasiri W; Boonyasuppayakorn S
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770642
[TBL] [Abstract][Full Text] [Related]
16. 8-Hydroxyquinoline a natural chelating agent from Streptomyces spp. inhibits A549 lung cancer cell lines via BCL2/STAT3 regulating pathways.
Balthazar JD; Soosaimanickam MP; Emmanuel C; Krishnaraj T; Sheikh A; Alghafis SF; Ibrahim HM
World J Microbiol Biotechnol; 2022 Aug; 38(10):182. PubMed ID: 35953631
[TBL] [Abstract][Full Text] [Related]
17. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic Genes of Bax, Bad, Bcl2, and P53 in A549 Lung Cancer Cells Comparison of the Effect of Echinophora platyloba DC. Extract and Cordia myxa L Extract on the Expression of Apoptotic Genes of Bax, Bad, Bcl2, and P53 in A549 Lung Cancer Cells.
Kalantari M; Entezari M; Movafagh A; Hushmandi K; Dehghani H
Gulf J Oncolog; 2021 Jan; 1(35):7-13. PubMed ID: 33716207
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents.
Korkmaz IN; Özdemir H
Appl Biochem Biotechnol; 2022 Dec; 194(12):6349-6366. PubMed ID: 35917102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
